MedTrace Logo

Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma

NCT01715597 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-10-31

No results posted yet for this study

Summary

The investigators want to know whether the intravenous ascorbic acid would reduce the blood loss during laparoscopic myoma surgery. The investigators randomized patients into intravenous ascorbic acid group and placebo group and examined the blood loss in both groups.

Conditions

  • Uterine Leiomyoma

Interventions

DRUG

ascorbic acid

ascorbic acid 2g in normal saline 500ml IV start 30min before the operation and infusion for 2 hour

DRUG

Normal saline

normal saline 500ml IV

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • kiding kim, M.D. · Seoul National University Bundang Hospital,Gyeongg-ido,Republic of Korea

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • South Korea

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01715597 on ClinicalTrials.gov